Precision Medicine for Epitranscriptome Machinery
CatchMe Therapeutics develops a solution for specific inhibition based on the in vivo biological binding preference of targeted proteins. The company's versatile platform can be expanded to target different methyl binding proteins and different indications.
| Name | CatchMe Theraputics |
|---|---|
| Slug | catchme-theraputics |
| Type / kind | startup |
| Source _id | emKJyaS3AEzL2oByNresmGZiMiqXwcRSN8QcXjNo4GtFtWO0Kjrg5r |
| Status | active |
|---|---|
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ city | Ness Ziona |
| HQ address | Park Hamada Ilan Ramon St 2, Ness Ziona, Israel |
| https://www.linkedin.com/company/81306978 |
| Total raised | — |
|---|---|
| Current stage | Pre-Seed |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}